Jennifer Cook

Jennifer Cook is a healthcare executive with over two decades of experience in the industry. Jennifer is currently the advisor at Deep Genomics, and was previously the CEO and Board Director of GRAIL, Inc. from January 2018 to June 2019. Prior to that, they were the Senior Vice President, Business Unit Head of Immunology and Ophthalmology at Genentech from January 2010 to December 2013, and Roche's Senior Vice President and Global Head of Clinical Operations from August 2013 to December 2017. Jennifer has also held leadership positions at Ambys Medicines, BridgeBio, Jennifer Cook Consulting, and Denali Therapeutics. Throughout their career, Jennifer has been dedicated to improving patient care and outcomes through innovative products and treatments.

Jennifer Cook has a Master of Business Administration (MBA) from the University of California, Berkeley, Haas School of Business and a Master's degree in Biology from Stanford University. Jennifer also has a Bachelor's degree in Human Biology from Stanford University.